Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Only logged in customers who have purchased this product may leave a review.
You may also like
Before starting an S2P project, it is necessary to be aware that data related topics are crucial to ensure a proper operation of the solution. Our clients often do not enough focus on data issues and do not consider data as one of the pillars to succeed in implementing their S2P project.
12 Recommendation to Implement a Source-To-Pay Solution$0.00 Axbility Consulting
Building The Automotive Industry of 2030$0.00 Oliver Wyman
Demographic change, geopolitical turbulence and macroeconomic uncertainty. Disruptive technologies and exploding data volumes. Shifting regulatory requirements. An increasingly complex matrix of competitors, partners and vendors. The financial services industry faces an unprecedented quantum of change — one that will only expand and accelerate.
Moving from analog to digital$0.00 EY
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?